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ABSTRACT 
The diastereoselective synthesis of cis and trans steroid-fulleropyrrolidines hybrids by 
reaction of N-metalated azomethine ylides [Cu(II) or Ag(I)] with the appropriate chiral 
ligand and C60 is described. The experimental findings reveal that the azomethine ylide 
stabilized by an allylic group cycloadds to [60]fullerene in an efficient manner and with 
a good diastereomeric excess. Furthermore, the new generated stereocenters are fully 
controlled by the catalytic systems used without being influenced by the chirality of the 
steroid. Interestingly, by this synthetic methodology the each one of the four possible 
stereoisomers have efficiently been obtained and characterized by CD spectra.  
 
INTRODUCTION 
The use of fullerenes for bio-medical applications is still an underdeveloped research 
area.1 Therefore, synthetic approaches towards fullerenes covalently bonded to natural 
products are of interest.2 On the other hand, it is well known that steroids are biologically 
relevant molecules showing bio-medical applications.3,4 In this regard, conjugating 
steroids to fullerenes is a topic that has not been properly addressed so far that can lead 
to interesting molecules with different biological properties.5-11 
In previous work we have carried out the synthesis of new [60]fullerene–steroid 
hybrids following the Bingel-Hirsch methodology using cholesterol, β-sitosterol, and 
ergosterol as steroid moiety, affording a variety of methanofullerene conjugates 
exhibiting solubility in different organic solvents, thus obtaining promising functional 
chimeras with potential biomedical applications.12 Soon afterwards, we synthesized new 
molecular hybrids steroid-fullerenes, using the Prato´s procedure by 1,3-cycloaddition of 
the corresponding formyl-steroid, sarcosine and C60. In that case, we have selected the 
naturally occurring steroid epiandrosterone, which was conveniently functionalized. This 
reaction gives rise to the formation of diastereoisomeric mixture of fulleropyrrolidines 
with poor selectivity due to the generation of a new stereogenic center in the cyclization 
process.13 Recently, we have described the multistep preparation of a fullerene hybrid 
dumbbell endowed with two fullerene units connected through an epiandrosterone 
molecule. Suitably functionalized epiandrosterone required a previous chemical 
modification to introduce a formyl and a malonate groups for further covalent 
connectivity to the C60 units, first by 1,3-cycloaddition and then by a cyclopropanation  
reaction.14 In both cases the lack of asymmetric control on the new generated chiral 
centers gave stereoisomeric mixture. 
On the other hand, chirality in fullerenes has recently received a lot of attention 
because of its importance for preparing optically active compounds for potential use in 
medicinal chemistry as well as in materials science. 
The first successful methodology for obtaining pyrrolidinofullerenes with controlled 
stereochemistry was described by Martin´s group in 2009 using different copper and 
silver salts and chiral ligands.15 This procedure paved the way to the preparation of new 
and versatile chiral fullerenes at will. Particularly, chiral metal complexes described 
proved to be versatile catalysts affording optically pure pyrrolidinofullerenes by a fully 
stereodivergent cycloaddition of azomethine ylides.16  
Taking into account these aforementioned results, we have carried out a thorough and 
systematic study to expand the scope of this highly versatile stereoselective catalytic 
cycloaddition onto C60 to other catalysts and dipoles, reporting a fully stereodivergent 
methodology for the synthesis of chiral pyrrolidinofullerenes by the correct choice of a 
wide and easily available collection of chiral ligands, metals, and iminoesters or 
iminoamides.17  
The aforementioned results achieved in chiral fullerenes were reported in a 
comprehensive review published in 2014.18 All these outcomes pave the way to obtaining 
enantiomerically pure fullerenes and, therefore, to their use not only in biomedical 
applications, where chirality is an important issue, but also in materials science, where 
fullerenes find their main applications.  
With the aim to prepare steroid-fullerene hybrids with a controlled stereochemistry, 
here we report on the stereoselective 1,3-dipolar cycloaddition of steroid N-metalated 
azometine ylides to C60 using a suitable combination of chiral ligand and metal salts, at 
low temperature, affording each one of the four possible stereoisomers in good yields and 
high diasteromeric excess, surpassing de values of 93%. 
 
RESULTS AND DISCUSSION 
 
The stereoselective synthesis of steroid-fullerene hybrids from the 1,3-dipolar 
cycloaddition of the imine 2 onto C60 has been studied by the application of metal 
mediated asymmetric catalysis. Since in this process the configuration of the stereogenic 
centers of the steroid (3'S, 5'S, 8'R, 9'S, 10'S, 14'S) does not change during the course of 
the reaction, a mixture of up to four optically pure stereoisomer could arise from a no 
controlled formation of the two new formed stereogenic carbon atoms C2 and C5: (2R, 
5R), (2S, 5S), (2S, 5R) and (2R, 5S). 
The synthesis of the target compounds began with the generation of the imine 2 by 
mixing the previously reported13 3-chloro-2-formyl-17-oxo-5α-androstan-2-ene (1) and 
glycine methyl ester hydrochloride in the presence of triethylamine using dichlorometane 
as solvent at room temperature (See Scheme 1). This compound was obtained as a yellow 
oil in 77 % yield. 
The 1H NMR spectrum of 2 shows the disappearance of the signal corresponding to 
the proton of the formyl group at ∼10 ppm and the presence of a signal at 8.22 ppm 
assigned to the imine proton. In the 13C NMR spectrum appears signals at 170.6 ppm (O-
C=O) and other at 160.7 ppm assigned to the carbon of the imine group.  The structure of 
the compound was ascertained by mass spectrometry. The ESI-MS spectrum for 
compound 2 shows a peak at m/z = 472.3 which corresponds to [M + Na]+, thus supporting 
the proposed structure. 
The use of anhydrous silver acetate along with an achiral ligand [dppe, 1,2-
bis(diphenylphosphino)ethane] in toluene at room temperature limits the mixture 
composition to the two cis-diastereomers 3 and 4 as indicated by the appearance of two 
peaks at 6.96 and 10.71 minutes, respectively, in the HPLC chromatogram of the reaction. 
It is important to note, however, that the stabilization of the N-metalated azomethine ylide 
is provided by the allylic moiety of the steroid unit, thus resembling the benzylic one 
(moiety) in previous examples from literature.15 
The two monoadducts were separated by flash chromatography initially with carbon 
disulfide, to elute unreacted C60, followed by dichloromethane and dicloromethane: ethyl 
acetate (100:1) to obtain compounds 3 and 4, in 32% and 25% yield, respectively, (Table 
1, entry 1) see Scheme 1. These values show a modest stereoselectivity, as result of the 
poor chiral induction of the steroid moiety on the attack to one of the faces of the dipole 
in the fullerene derivative. 
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Scheme 1. Synthesis of cis diasteromers of fulleropyrrolidine-steroids hybrids. 
 
Monoaducts 3 and 4 were fully characterized by analytical and spectroscopic 
techniques (see the Experimental Section and Supporting Information). 1H NMR 
spectroscopy revealed the formation of compounds 3 and 4. Besides the disappearance of 
the methylene protons (δ = 4.31 ppm) present in 2, the spectra of compounds 3 and 4 
show the signals corresponding to the protons of the pyrrolidine ring at 5.57 ppm (H2) 
and 5.81 ppm (H5) for 3 and 5.58 ppm (H2) and 5.86 ppm (H5) for 4.  
The number of signals observed in the 13C NMR spectra between 156 ppm and 136 
ppm reveal the lack of symmetry in the fullerene cage in these compounds. The 13C NMR 
spectra show, for both 3 and 4, the presence of the fulleropyrrolidine ring on the 6,6-ring 
junction of the C60 framework at ∼77 ppm and ∼79 ppm, and those corresponding to the 
carbons of the fulleropyrrolidine ring appear at ∼73 ppm (C2) and ∼70 ppm (C5).  
HRMS verified the proposed structure. MALDI-TOF spectrum for compound 3, 
registered in the negative mode of detection, shows a peak at m/z = 1169.2330, 
corresponding to the odd-electron molecular ion M•−, while the MALDI-TOF spectrum, 
in positive mode of detection, for compound 4 shows a peak in m/z = 1192.2223 
corresponding to [M + Na]+.  (See Experimental Section and Supporting Information). 
In order to determine the spatial arrangement of the protons attached to carbons C2 
and C5, NOE experiments were performed on both diastereoisomers 3 and 4. (See 
Supporting Information Figure S7 and S19, respectively). In both cases, NOE effect was 
observed showing the spatial proximity of H2 and H5 protons, indicating the cis 
arrangement in both diastereomers. 
With the aim of assigning the absolute stereochemistry of the new stereogenic centers 
formed in the reaction, namely C2 and C5 of the pyrrolidine ring, we registered the CD 
spectra of both 3 and 4, (see Figure 1). The CD spectra do not present an exactly mirror 
relationship as expected for two diastereomers. However, inspection of the region around 
430 nm, considered as the finger print for every fullerene monoadductus, features peaks 
with opposite sign corresponding to opposite configurations at the new formed 
stereogenic centers (Figure 1). Indeed, by using the sector rule,19 proposed for fullerene 
derivatives,13-15 which links the Cotton effect (CE) associated with this UV−vis band and 
the stereochemical environment around the 6,6 junction, we could assign the 
configuration of both C2 and C5 atoms. 
Compound 3-cis showed in its CD spectrum a positive CE, which is consistent with a 
(2S,5R) stereochemistry (Figure 1, a). The negative CE observed in the CD spectrum of 
4-cis, indicates a (2R,5S) configuration (Figure 1, b). 
  
 
Figure 1. CD spectra of fulleroyrrolidines a) 3-(2S,5R)-cis, b) 4-(2R,5S)-cis, c) 5-(2R,5R)-
trans, d) 6-(2S,5S)-trans in CH2Cl2 (conc, 4 × 10-4 M). 
 
The stereochemical outcome stems from the attack of the C60 onto the Re,Si face of 
the prochiral C2 an C5 respectively in the case of the stereoisomer 3 and onto the opposite 
face for the stereoisomer 4(See Figure 2). The slight diastereomeric excess is consistent 
with a weak orientation (chiral induction) of the steroid moiety toward the Re,Si face.  
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Figure 2. Plausible pathway for  the cycloaddition reaction of C60 on the chiral metal 
complex. 
 
In order to ascertain if the previously reported catalytic systems15,16 were able to 
maintain their stereocontrol in the 1,3-dipolar cycloaddition of azomethine ylides onto 
C60 even in the presence of a chiral moiety such as the imine 2, we performed the reactions 
using the conditions previously reported. Thus, the catalytic complex Cu(II)–Fesulphos 
at 0 oC, directs the 1,3-dipolar cycloaddition of steroid iminoester 2 onto C60 affording 
cis-(2S,5R)-2-methoxycarbonyl-5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene) 
pyrrolidino[3,4:1,2] [60]fullerene (3) with an excellent diastereomeric induction. (See 
Scheme 2 and Table 1, entry 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Asymmetric Cu(II) and Ag(I)-catalysed 1,3-dipolar cycloadditions of steroid 
azomethine ylide to C60 using different chiral ligands. 
 
Entrya Metal/Liganda Temp oC Conversion %b 3-(2S,5R)-
cis % 
4-(2R,5S)-
cis % 
5-(2R,5R)- 
trans % 
6-(2S,5S)-
trans % 
1 Ag(AcO)/dppe rt 60  32 25   
2 Cu(AcO)2/FeSulphos 0 80 94 6   
3 AgOAc/(R,R)-BPE 0 88 7 93   
4 Cu(OTf)2/R-DTBM-
Segphos/Et3N 
rt 90   95 5 
5 Cu(OTf)2/S-DTBM-
Segphos/Et3N 
rt 91   7 93 
(a) Conditions (cycloaddition): metal salt (10% mol), chiral ligand (10% mol), anhydrous 
toluene, 2 h; (b) determined by hplc analysis.  
 
Changing the catalytic system to AgOAc/(R,R)-BPE at the same temperature (See 
Scheme 2 and Table 1, entry 3) the cis-diastereoisomer (2R,5S) (cis-2-methoxycarbonyl-
5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene)pyrrolidino[3,4:1,2][60]fullerene (4) with 
the opposite configuration is obtained also with excellent diasteroselecivity. Despite the 
stereoselectivity is slightly lower as result of a mismatched chiral induction between the 
steroid (2R) and the catalyst (2S), the system Ag/BPE is still able to maintain high de 
values. In both catalysts, the counterion of the metal salt is acetate because it acts as a 
base and, probably, occupies the vacancy in the metal coordination sphere, thus enabling 
a better stereodifferentiation.15  
For completing the diastereodivergent study was important to obtain the trans-
diastereoisomers. For this, previously reported conditions were used16,17 employing the 
bulky chiral ligand DTBM-Segphos.  
In this regard, the complex Cu(II)–(R)-DTBM-Segphos in the presence of 
triethylamine as a base at room temperature gives a trans-diastereoisomer 5, (See Scheme 
2 and Table 1, entry 4) with retention time of 5.9 min and a positive CE at 430 nm, 
corresponding with a (2R,5R) configuration (See Figure 1, c). The use of Cu(II)–(S)-
DTBM-Segphos under the same conditions gives a trans-diastereoisomer 6 (retention 
time 8.4 min) with (2S,5S), (See Scheme 2 and Table 1, entry 5) configuration, consistent 
with the negative CE at 430 nm, as it is shown in the CD spectrum (Figure 1, d). 
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Scheme 2. Stereodivergent synthesis of the four diastereoisomers of 2-methoxycarbonyl-
5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene)pyrrolidine[3,4:1,2][60]fullerene. 
Reagents and conditions: (i) ClNH3CH2COOEt, Et3N, DCM anh, rt; (ii) Cu(AcO)2, 
Fesulphos, 0 oC, 2 h; (iii) Ag(OAc), BPE, 0 oC, 2 h; (iv) Cu(OTf)2, R-DTBM-Segphos, 
Et3N, 2 h, rt; (v) Cu(OTf)2, S-DTBM-Segphos, Et3N, 2 h, rt. 
 
 
To confirm the trans stereochemistry of diastereoisomers 5 and 6, ROESY-1D spectra 
were recorded and no interaction between H2 and H5 protons was observed, indicating 
the trans arrangement between them. (See Suporting Information, Figure S30 for 5 and 
Figure S41 for 6). 
The spectroscopical data confirm the structure of both trans-diastereomeric hybrids 5 
and 6 which are very similar to the cis-diastereisomers 3 and 4. (see the Experimental 
Section and Supporting Information).1H NMR shows the signals corresponding to the 
protons of the pyrrolidine ring at 5.57 ppm (H2) and 5.84 ppm (H5) for 5 and 5.57 ppm 
(H2) and 5.81 ppm (H5) for 6.  
The 13C NMR spectra shows, for both 5 and 6, signals at ∼76 ppm and ∼79 ppm, 
indicating the 6,6-ring junction of C60 to pyrrolidine ring, and those corresponding to the 
carbons of the fulleropyrrolidine ring which  appear at ∼74 ppm (C2) and ∼70 ppm (C5). 
Also the signals at the interval of 156-136 ppm, denote the presence of the fullerene cage.  
MALDI-TOF spectrum for compound 5, registered in the positive mode of detection, 
shows a peak at m/z = 1170.2405, corresponding to [M + H]+ ion, while the mass spectrum 
of 6 shows a peak at m/z = 1170.2453 corresponding to [M + H]+ (See Supporting 
Information). 
The chemical structure of all final compounds (3-6) was confirmed by combined NMR 
spectroscopic data from 1H, 13C, COSY, DEPT, HMQC, and HMBC experiments. (See 
Supporting Information).   
Also the specific optical rotation measurements for the hybrids were carried out. Thus, 
the experimentally determined values for [α]D20  were: + 125o for 3-cis, +40o for 4-cis, 
+105o for 5-trans and +35o for 6-trans. 
The 1,3-dipolar cycloaddition between the steroidal imine 2 and [60]fullerene is 
coherent with the previous results obtained by Martin et al. for the synthesis of 
stereodivergent chiral fulleropyrrolidines.15 
 
CONCLUSIONS 
In summary, we have carried out for the first time a controlled diastereoselective synthesis 
of chiral steroid-fulleropyrrolidines by reaction of copper or silver N-metalated 
azomethine ylide and chiral ligands. Depending on the chiral metal/ligand employed, it 
is possible to obtain the pairs of cis and trans diastereomers with good diastereomeric 
excesses and good yields.  The new steroid-fullerene hybrids have been characterized by 
spectroscopic and dichroic study which reveal the formation of the four different 
stereoisomers. Importantly, these results show that the azomethine ylides stabilized by an 
allylic group generated from the steroidal imine 2, behaves in a similar favorable way to 
that observed for the benzyl related compounds in previous studies (see above). 
In contrast to previous papers involving steroid-fullerene hybrids where only poor 
stereoselectivities were achieved, the stereodivergent protocol now presented shows the 
efficiency for the preparation of diastereoselective derivatives in a controlled manner, 
thus paving the way to a great variety of optically active fullerene derivatives.  
 
EXPERIMENTAL 
 
General Experimental Methods. All reactions were performed using an atmosphere 
of argon and oven-dried glassware. Solvents were treated prior to use according to the 
standard methods. The commercially available reagents were used without further 
purification. Reactions were monitored by thin-layer chromatography carried out on 0.25 
mm silicagel plates (230−400 mesh). Flash column chromatography was performed using 
silica gel (60 Å, 32−63 μm). FTIR spectra were recorded in CHCl3. 1H-NMR spectra were 
recorded at 700 MHz and 13C-NMR at 175 MHz; the one-bond heteronuclear correlation 
(HMQC) and the long-range 1H−13C correlation (HMBC) spectra were obtained by use 
of the inv4gs and the inv4gslplrnd programs. All MS-ESI and HRMS-MALDI (dithranol 
as matrix) experiments were carried out in negative and positive modes of detection. 
UV/vis spectra were recorded in CHCl3. Microanalysis was performed with a CHN 
instrument. Optical rotations were measured using a polarimeter with a thermally jacketed 
10 cm cell at 20ºC (concentration given as g/100ml). The CD spectra were recorded in 
dichloromethane.  A high-performance liquid chromatography (HPLC) system (column 
dimensions, 4.6 × 250 mm; flow rate 1.0 mL min−1, injection volume 15 μL, eluent  
toluene:acetonitrile 9:1) was used to determine the purity of the compounds synthesized 
and de values All these values were monitored in a 320 nm spectrophotometer detector.  
 
N-methyl [(3β-acetoxy-17-chloro-16-androstene-16-yl) methylene] glycinate) (2). A 
mixture of glycine methyl ester hydrochloride 75 mg (0.6 mmol) and triethyl amine 0.26 
mL (1.8 mmol) with molecular sieves (4Å) in 40 mL of anhydrous dichloromethane 
(DCM) was stirred for one hour. Then, 3β-acetoxy-17-chloro-16-formyl-5α-16-
androstene 160 mg (0.42 mmol) was added and the reaction was stirred overnight at room 
temperature. The reaction mixture was filtered to separate the molecular sieves and the 
filtrate was washed twice with water and subsequently over anhydrous MgSO4. The 
organic extract was concentrated, obtaining a yellow oil. Yield 77 % (145 mg). 1H-NMR 
(700 MHz, CDCl3, δ ppm): 8.22 (s, 1H, CH=N), 4.67 (m, 1H, H3), 4.31 (s, 2H, NCH2CO), 
3.76 (s, 3H, CH3O), 2.63 (dd, J = 14.7 Hz, J = 6.0 Hz, 1H, H15), 2.04 (m, 1H, H15), 2.01 
(s, 3H, CH3-CO), 1.84 (m, 1H, H2), 1.78 (m, 1H, H7), 1.73 (m, 1H, H1), 1.67 (m, 2H, 
H11), 1.63 (m, 1H, H4), 1.59 (m, 1H, H14), 1.57 (m, 1H, H8), 1.51 (m, 1H, H2), 1.46 (m, 
1H, H12), 1.42 (m, 1H, H12), 1.38 (m, 1H, H4), 1.33 (m, 2H, H11), 1.30 (m, 2H, H6), 
1.20 (m, 1H, H5), 1.03 (m, 1H, H1), 0.97 (m, 1H, H7), 0.84 (m, 1H, H9).0.82 (s, 3H, 
CH3-19), 0.74 (s, 3H, CH3-18). 13C-NMR (175 MHz, CDCl3, δ ppm): 170.7 (C=O), 170.6 
(C=O), 160.7 (CH=N), 152.7 (C17), 134.9 (C16), 73.5 (C3), 62.3 (NCH2CO), 54.6 (C14), 
53.9 (C9), 52.2  (CH3O), 49.9 (C13), 44.8 (C5), 36.5 (C1), 35.7 (C10), 34.0 (C8), 33.9 
(C12), 33.4 (C4), 31.1 (C7), 28.3 (C15), 28.2 (C6), 27.4 (C2), 21.5 (CH3-CO), 20.7 (C11), 
15.2 (C18), 12.2 (C19). IR (CHCl3): ν = 3242, 2927, 2858, 1732 (C=O), 1674, 1244, 
1026, 756 cm-1. C25H36ClNO4 (449.23): calcd. C 66.72, H 8.06; found C 66.75, H 8.10. 
MS (MALDI-TOF) m/z: [M + Na]+ 472.3. 
cis-(2S,5R)-2-Methoxycarbonyl-5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene) 
pyrrolidino[3,4:1,2][60]fullerene (3). A mixture of Cu(OAc)2 (1 mg) and Fesulfos (2.3 
mg) in anhydrous toluene (10 mL) was stirred for one hour at room temperature. Then, 
20 mg of steroid α-iminoester 1 was added and the yellow mixture was cooled at 0oC. 
Finally, 30 mg (0.042 mmol) of C60 was also added. The reaction mixture was stirred for 
two hours, and afterwards, it was quenched with an aqueous saturated ammonium 
chloride solution (3 mL). The mixture was extracted with toluene (3 x 1mL), and the 
combinated extracts were washed with brine (3 mL). The organic layer was dried over 
MgSO4 and concentrated in vacuo. The solid crude was purified by column 
chromatography on silica gel, using CS2 to elute unreacted C60 and dichloromethane to 
elute the corresponding pyrrolidine [3,4:1.2][60]fullerene 3. Brown solid, melting point 
over 350º C. Chemical yield: 60 % (29 mg). HPLC: toluene, flow rate 1 mL/min, tR = 
6.96 min. [α]D20 = +125º (c 2 x 10-4 CH2Cl2). 1H-RMN (700 MHz, CDCl3, δ ppm): 5.81 
(s, 1H, H5), 5.57 (s, 1H, H2), 4.65 (m, 1H, H3’), 3.90 (s, 3H, CH3O), 2.60 (dd, J = 14.5 
Hz, J = 6.3 Hz, 1H, H15’), 2.44 (dd, J = 14.4 Hz, J = 11.6 Hz, 1H, H15’), 2.03 (s, 3H, 
CH3CO), 1.80 (m, 1H, H2’), 1.77 (m, 1H, H12’), 1.74 (m, 1H, H7’), 1.68 (m, 1H, H1’), 
1.61 (m, 1H, H8’), 1.60 (m, 1H, H11’), 1.58 (m, 1H, H4’), 1.47 (m, 1H, H2’), 1.37 (m, 
1H, H11’), 1.35 (m, 1H, H4’), 1.33 (m, 1H, H14’), 1.30 (m, 2H, H6’), 1.21 (m, 1H, H12’), 
1.17 (m, 1H, H5’), 1.01 (s, 3H, CH3-18’), 0.99 (m, 1H, H1’), 0.86 (s, 3H, CH3-19’), 0.82 
(m, 1H, H7’), 0.67 (m, J = 4.6 Hz, 1H, H9’). 13C-RMN (175 MHz, CDCl3, δ ppm): 170.7 
(C=O); 169.9 (C=O-C2), 153.3, 152.5, 151.7, 150.7, 147.2, 147.0, 146.5, 146.4, 146.33, 
146.29, 146.2, 146.1, 145.9, 145.5, 145.4, 145.38, 145.35, 145.3, 145.2, 145.16, 145.1, 
144.9 (C17’), 144.5, 144.3, 144.2, 144.1, 143.2, 143.1, 143.0, 142.8, 142.7, 142.7, 142.5, 
142.4, 142.3, 142., 142.1, 142.0, 141.9, 141.8, 141.6, 140.0, 139.8, 139.7, 139.6, 136.6, 
136.1, 135.3, 134.8, 132.0 (C16’), 79.8 (Csp3 C60), 76.9 (Csp3 C60), 74.0 (C2), 73.5 (C3’), 
70.5 (C5), 55.2 (C14’), 54.5 (C9’), 53.5 (CH3O), 48.9 (C13’), 44.6 (C5’), 36.3 (C1’), 35.7 
(C10’), 34.2 (C12’), 33.9 (C4’), 33.7 (C8’), 32.2 (C15’), 31.4 (C7’), 28.2 (C6’), 27.4 
(C2’), 21.5 (CH3CO), 20.8 (C11’), 15.1 (C18’), 12.2 (C19’). IR (CHCl3): ν = 2924, 2854, 
1737 (C=O), 1249, 1025, 755 cm–1. HRMS (MALDI-TOF) m/z: [M●-] Calcd for 
C85H36ClNO4 1169.2338; Found 1169.2330. 
 
cis-(2R,5S)-2-Methoxycarbonyl-5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene) 
pyrrolidino[3,4:1,2][60]fullerene. (4). A mixture of AgOAc (1 mg) and BPE (2.3 mg) in 
toluene anhydrous (10 mL) in toluene anhydrous (10 mL) was stirred for one hour at room 
temperature. Then, 20 mg of steroid α-iminoester 1 was added and the yellow mixture 
was cooled at 0oC. Finally, 30 mg (0.042 mmol) of C60 was also added. The reaction 
mixture was stirred for two hours, and afterwards, it was quenched with an aqueous 
saturated ammonium chloride solution (3 mL). The mixture was extracted with toluene 
(3 x 1mL), and the combinated extracts were washed with brine (3 mL). The organic layer 
was dried over MgSO4 and concentrated in vacuo. The solid crude was purified by column 
chromatography on silica gel, using CS2 to elute unreacted C60 and dichloromethane:ethyl 
acetate (100:1)  to elute the corresponding pyrrolidine [3,4:1.2][60]fullerene 4. Brown 
solid, melting point over 350º C. Chemical yield: 57 % (27 mg). HPLC: toluene, flow 
rate 1 mL/min, tR = 10.71 min. [α]D20 = +40º (c 2 x 10-4 CH2Cl2). 1H-RMN (700 MHz, 
CDCl3, δ ppm): 5.86 (s, 1H, H5), 5.58 (s, 1H, H2), 4.71 (m, 1H, H3’), 3.90 (s, 3H, CH3O), 
2.72 (dd, J = 14.5 Hz, J = 6.4 Hz, 1H, H15’), 2.14 (dd, J = 13.8 Hz, J = 11.9 Hz, 1H, 
H15’), 2.03 (s, 3H, CH3CO), 1.83 (m, 1H, H2’), 1.80 (m, 1H, H7’), 1.77 (m, 1H, H12’), 
1.73 (m, 1H, H14’), 1.70 (m, 1H, H1’), 1.66 (m, 1H, H11’), 1.62 (m, 1H, H8’), 1.57 (m, 
1H, H4’), 1.49 (m, 1H, H2’), 1.40 (m, 1H, H12’), 1.38 (m, 1H, H4’), 1.35 (m, 1H, H11’), 
1.33 (m, 1H, H6’), 1.29 (m, 1H, H6’), 1.24 (m, 1H, H5’), 1.09 (m, 1H, H7’), 1.03 (m, 1H, 
H1’), 0.84 (m, 1H, H9’), 0.83 (s, 3H, CH3-19’), 0.75 (s, 3H, CH3-18’). 13C-RMN (175 
MHz, CDCl3, δ ppm): 170.9 (CO-20’), 170.1 (CO-C2), 153.6, 152.9, 152.1, 150.9, 147.3, 
147.2, 146.7, 146.5, 146.44, 146.42, 146.38, 146.2, 146.1, 146.0, 145.7, 145.60, 145.57 
(C17’), 145.5, 145.47, 145.39, 145.35, 145.33, 145.30, 144.5, 144.48, 144.45, 144.3, 
143.27, 143.25, 143.17, 142.92, 142.89, 142.84, 142.81, 142.76, 142.6, 142.4, 142.3, 
142.2, 142.14, 142.11, 142.09, 142.06, 141.98, 141.2, 139.90, 139.83, 139.75, 136.8, 
136.25, 136.17, 135.0, 131.7 (C16’), 79.4 (Csp3 C60), 76.9 (Csp3 C60), 73.8 (C2), 73.7 
(C3’), 70.7 (C5), 55.12 (C14’), 54.7 (C9’), 53.0 (OCH3), 49.1 (C13’), 44.9 (C5’), 36.6 
(C1’), 35.9 (C10’), 34.10 (C8’), 34.08 (C4’), 33.6 (C12’), 32.1 (C15’), 31.4 (C7’), 28.4 
(C6’), 27.5 (C2’), 21.6 (C21’), 20.8 (C11’), 16.2 (C18’), 12.3 (C19’). IR (CHCl3): ν = 
2928, 2853, 1737 (C=O), 1249, 1025, 754 cm–1. HRMS (MALDI-TOF) m/z: [M + Na]+ 
Calcd for C85H36ClNO4Na 1192.2225; Found 1192.2223. 
 
trans-(2R,5R)-2-Methoxycarbonyl-5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene) 
pyrrolidino[3,4:1,2][60]fullerene. (5). A mixture of cooper(II)triflate (1.9 mg) and R-
DTBM-Segphos (6 mg) in toluene anhydrous (10 mL) was stirred for one hour at room 
temperature, getting a solution with a slight blue colour. Then, 23.5 mg of steroid α-
iminoester 1 was added obtaining a yellow mixture. Finally, C60 (33.6 mg) and 0.2 mL of 
triethylamine were added. The reaction mixture was stirred for two hours, and afterwards, 
it was quenched with an aqueous saturated ammonium chloride solution (5 mL). The 
mixture was extracted with toluene (3 x 10 mL), and the combinated extracts were washed 
with brine (10 mL). The organic layer was dried over MgSO4 and concentrated in vacuo. 
The crude product was purified by column chromatography on silica gel, using CS2 to 
elute unreacted C60 and dichloromethane to elute the corresponding pyrrolidine 
[3,4:1.2][60]fullerene 5. Chemical yield: 62 % (29 mg). Brown Solid. HPLC: toluene, 
flow rate 1 mL/min, tR = 5.91 min. [α]D20 = +105º (c 2 x 10-4 CH2Cl2). 1H-NMR(700 
MHz, CDCl3, δ ppm): 5.84 (s, 1H, H5), 5.57 (s, 1H, H2), 4.65 (m, 1H, H3’), 3.66 (s, 3H, 
CH3O), 2.60 (m, 1H, H15’), 2.44 (m, 1H, H15’), 2.01 (s, 3H, CH3CO), 1.82 (m, 1H, H2’), 
1.78 (m, 1H, H12’), 1.76 (m, 1H, H7’), 1.70 (m, 1H, H1’), 1.63 (m, 1H, H11’), 1.61 (m, 
1H, H8’), 1.58 (m, 1H, H4’), 1.50 (m, 1H, H2’), 1.39 (m, 1H, H11’), 1.38 (m, 1H, H4’), 
1.37 (m, 1H, H14’), 1.33 (m, 1H, H6’), 1.29 (m, 1H, H6’), 1.23 (m, 1H, H12’), 1.18 (m, 
1H, H5’), 1.02 (m, 1H, H1’), 0.89 (s, 3H, CH3-18’), 0.85 (s, 3H, CH3-19’), 0.82 (m, 1H, 
H7’), 0.68 (m, 1H, H9’). 13C-NMR (175 MHz, CDCl3, δ ppm): 170.61 (CO-20’), 169.70 
(CO-C2), 147.14, 147.00, 146.34, 146,23, 145.99, 145.94, 145.57, 145.44, 145.40, 
145.33, 145.26, 145.14, 144.51, 143.31, 144.25, 143.15, 143.09, 142.74, 142.73, 142.68, 
142.65, 142.54, 142.41, 142.30, 142.28, 142.14, 142.05, 142.04, 142.00, 141.91, 140.03, 
139.68, 137.86 (C17’), 129.02 (C16’), 79.68 (Csp3 C60), 76.38 (Csp3 C60), 74.09 (C2), 
73.47 (C3’), 70.74 (C5), 70.57 (OCH3), 55.17 (C14’), 54.48 (C9’), 48.86 (C13’), 44.64 
(C5’), 36.32 (C1’), 35.71 (C10’), 34.25 (C4’), 33.90 (C12’), 33.71 (C8’), 31.34(C15’), 
29.69 (C7’), 28.21 (C6’), 27.36 (C2’), 21.43 (C21’), 20.66 (C11’), 14.35 (C18’), 12.15 
(C19’).  IR (CHCl3): ν = 2923, 2854, 1738, 1678, 1522, 743 cm–1. HRMS (MALDI-TOF) 
m/z: [M + H]+ Calcd for C85H37ClNO4 1170.2411; Found 1170.2405. 
 
trans-(2S,5S)-2-methoxycarbonyl-5-(3’β-acetoxy-17’-chloro-5’α-16’-androstene 
pyrrolidino[3,4:1,2][60]fullerene (6). A mixture of cooper(II)triflate (2 mg) and S-
DTBM-Segphos (6 mg) in toluene anhydrous (10 mL) was stirred for one hour at room 
temperature, getting a solution with a slight blue colour. Then, 23.5 mg of steroid α-
iminoester 1 was added obtaining a yellow mixture. Finally, C60 (33 mg) and 0.2 mL of 
triethylamine were added. The reaction mixture was stirred for two hours, and afterwards, 
it was quenched with an aqueous saturated ammonium chloride solution (5 mL). The 
mixture was extracted with toluene (3 x 10mL), and the combinated extracts were washed 
with brine (10 mL). The organic layer was dried over MgSO4 and concentrated in vacuo. 
The crude product was purified by column chromatography on silica gel, using CS2 to 
elute unreacted C60 and dichloromethane:ethyl acetate (99:1)  to elute the corresponding 
pyrrolidine [3,4:1.2][60]fullerene 6. Chemical yield: 63 % (30 mg). Brown Solid. HPLC: 
solvent toluene, flow rate 1 mL/min, tR = 8.42 min. [α]D20 = +35º (c 2 x 10-4 CH2Cl2). 1H-
NMR (700 MHz, CDCl3, δ ppm): 5.81 (s, 1H, H5), 5.57 (s, 1H, H2), 4.69 (m, 1H, H3’), 
3.90 (s, 3H, CH3O), 2.60 (m, 1H, H15’), 2.44 (m, 1H, H15’), 2.01 (s, 3H, CH3CO), 1.82 
(m, 1H, H2’), 1.77 (m, 1H, H12’), 1.76 (m, 1H, H7’), 1.70 (m, 1H, H1’), 1.61 (m, 1H, 
H11’), 1.60 (m, 1H, H8’), 1.58 (m, 1H, H4’), 1.49 (m, 1H, H2’), 1.39 (m, 1H, H4’), 1.38 
(m, 1H, H14’), 1.37 (m, 1H, H11’), 1.34 (m, 1H, H6’), 1.31 (m, 1H, H6’), 1.22 (m, 1H, 
H12’), 1.18 (m, 1H, H5’), 1.02 (m, 1H, H1’), 0.89 (s, 3H, CH3-18’), 0.86 (s, 3H, CH3-
19’), 0.83 (m, 1H, H7’), 0.67 (m, 1H, H9’). 13C-NMR (175 MHz, CDCl3, δ ppm): 170.7 
(CO-20’), 169.9 (CO-C2), 147.1, 147.0, 146.3, 146.0, 145.6, 145.4, 145.3, 145.2, 144.5, 
144.3, 144.2, 143.2, 143.1, 142.74, 142.67, 142.65, 142.5, 142.4, 142.3, 142.1, 142.05, 
142.00, 141.9, 141.8, 140.04, 140.03, 139.7, 138.0 (C17’), 128.9 (C16’), 79.8 (Csp3 C60), 
77.2 (Csp3 C60), 74.1 (C2), 73.5 (C3’), 70.6 (OCH3), 70.5 (C5), 55.2 (C14’), 54.5 (C9’), 
48.9 (C13’), 44.6 (C5’), 36.4 (C1’), 35.7 (C10’), 34.3 (C4’), 33.9 (C12’), 33.7 (C8’), 31.4 
(C15’), 29.4 (C7’), 28.2 (C6’), 27.4 (C2’), 21.5 (C21’), 20.7 (C11’), 14.2 (C18’), 12.2 
(C19’). IR (CHCl3): ν = 2924, 2853, 1738, 1250, 1025, 723 cm–1. HRMS (MALDI-TOF) 
m/z: [M + H]+ Calcd for C85H37ClNO4 1170.2411; Found 1170.2453. 
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